Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy.
about
Treatment trends for patients with brain metastases: Does practice reflect the data?Brain metastases from hepatocellular carcinoma: recent advances and future avenuesConcurrent Afatinib and Whole-Brain Radiotherapy in Exon 19-del-EGFR Mutant Lung Adenocarcinoma: A Case Report and Mini Review of the Literature.Enhancing Anticancer Effect of Gefitinib across the Blood-Brain Barrier Model Using Liposomes Modified with One α-Helical Cell-Penetrating Peptide or Glutathione and Tween 80.Combined action of EGFR tyrosine kinase inhibitors and whole-brain radiotherapy on EGFR-mutated non-small-cell lung cancer patients with brain metastasis.Icotinib combined whole brain radiotherapy for patients with brain metastasis from lung adenocarcinoma harboring epidermal growth factor receptor mutation.A Neuro-oncologist's Perspective on Management of Brain Metastases in Patients with EGFR Mutant Non-small Cell Lung Cancer.Systemic therapies in the treatment of non-small-cell lung cancer brain metastases.Non-small cell lung cancer (NSCLC) and central nervous system (CNS) metastases: role of tyrosine kinase inhibitors (TKIs) and evidence in favor or against their use with concurrent cranial radiotherapy.Challenges in the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer with brain metastases.State of the art of chemotherapy for the treatment of central nervous system metastases from non-small cell lung cancer.Blood-brain barrier permeability of normal-appearing white matter in patients with vestibular schwannoma: A new hybrid approach for analysis of T1 -W DCE-MRI.Paradigm shift of therapeutic management of brain metastases in EGFR-mutant non-small cell lung cancer in the era of targeted therapy.Is afatinib a treatment option for brain metastases in patients with EGFR mutation-positive non-small cell lung cancer?Emerging uses of biomarkers in lung cancer management: molecular mechanisms of resistance.Response to afatinib in treatment-naïve patients with advanced mutant epidermal growth factor receptor lung adenocarcinoma with brain metastases.Combined irradiation and targeted therapy or immune checkpoint blockade in brain metastases: toxicities and efficacy.Pharmacotherapeutic options for treating brain metastases in non-small cell lung cancer.Presence of pleural effusion is associated with a poor prognosis in patients with epidermal growth factor receptor-mutated lung cancer receiving tyrosine kinase inhibitors as first-line treatment.Current progress and outcomes of clinical trials on using epidermal growth factor receptor-tyrosine kinase inhibitor therapy in non-small cell lung cancer patients with brain metastases.Targeted DNA sequencing of non-small cell lung cancer identifies mutations associated with brain metastases.
P2860
Q31160473-A4FBC024-31E6-4283-9C97-4E14CB94BB0DQ33649050-65B4462C-1F90-4720-91BF-4A60D8981FB8Q33653615-A9898C22-26B4-44B5-A2B1-BC66E0106627Q36212979-6B49D3B5-15E4-4368-BA6B-4302A39FE935Q36684011-B047D41C-E6D8-4E32-AD38-1BAA16DB3AD7Q37121543-FCEA74F5-62C9-4CA3-8395-AA14BC341045Q37742623-233E232B-C588-49FC-8891-7E1D103115CBQ38738053-D278B03A-5D36-4270-A3BB-D4C2000984E2Q38763104-5360A45B-5B14-4E40-BCF6-AA5426B947FFQ38792519-93623C5F-CC04-4729-8CC0-A9BA51A59216Q38985340-989F594D-11BF-4769-81A8-E03F7C0BFC62Q39002038-53A186D0-F073-4DD4-A2BA-2277455972D1Q39337110-BD13DE9E-10C7-4068-B457-7660215107D1Q41954795-3E6EEAD4-E4C9-4886-AB6F-D04255E73F80Q46071509-96208DC3-6D33-45CD-9082-2243BBEA8C59Q47367544-803D08EC-90BC-4FE6-B01A-2BE8FBD8D4D1Q47768004-54D1B640-5A14-4BD1-8391-A60AEFDAA2F9Q50927730-52C1F793-4106-41C3-B544-FED86E1D2E87Q51168062-1EE68752-6365-406C-BCF4-B06E2EE468D5Q52709759-5BDAFB60-DE7B-4870-A6D3-4003E71FEB1AQ55117380-4D4520D1-368A-496F-8CFF-3010EC8DB2BD
P2860
Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Blood-brain barrier permeabili ...... whole brain radiation therapy.
@ast
Blood-brain barrier permeabili ...... whole brain radiation therapy.
@en
type
label
Blood-brain barrier permeabili ...... whole brain radiation therapy.
@ast
Blood-brain barrier permeabili ...... whole brain radiation therapy.
@en
prefLabel
Blood-brain barrier permeabili ...... whole brain radiation therapy.
@ast
Blood-brain barrier permeabili ...... whole brain radiation therapy.
@en
P2093
P2860
P356
P1433
P1476
Blood-brain barrier permeabili ...... whole brain radiation therapy.
@en
P2093
Jian-Zhong Liang
Li-Kun Chen
Shu-Xiang Ma
Wei-Dong Wei
Xiao-Xiao Dinglin
Yin-Duo Zeng
P2860
P304
P356
10.18632/ONCOTARGET.3187
P407
P577
2015-04-01T00:00:00Z